Diarrhea - Chemically induced
Research News and Information

Monday, November 23, 2009

Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience.

29 Nov 2009 BACKGROUND: The prognosis for recurrent/progressive Ewing sarcoma (ES) remains poor. Pre-clinical, adult phase I and II trials have demonstrated the combination of irinotecan and temozolomide to have schedule-dependent synergy and significant ... Read more...

Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation.

30 Aug 2009 In the armamentarium for rhythm control, amiodarone has been a mainstay of therapy for the management of atrial fibrillation (AF). Although amiodarone has shown to be effective in maintaining sinus rhythm, it has many extracardiac adverse effects. ... Read more...

High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses.

29 Aug 2009 PURPOSE: Long-term clinical outcome data have established imatinib 400 mg/d as standard front-line treatment for newly diagnosed patients with chronic myeloid leukemia (CML). PATIENTS AND METHODS: The Rationale and Insight for Gleevec High-Dose ... Read more...

Latest indexed articles for 'Diarrhea - Chemically induced'

These are the very latest articles for this heading:

• Irinotecan and temozolomide for Ewing sarcoma: the Memorial Sloan-Kettering experience. 29 Nov 2009
• Chronic diarrhea responding to proton pump inhibitors: a clinical sign of Zollinger-Ellison syndrome. 30 Oct 2009
• Dronedarone: a new antiarrhythmic agent for the treatment of atrial fibrillation. 30 Aug 2009
• High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses. 29 Aug 2009
• Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group. 22 Aug 2009
• [Diarrhea after antibiotic therapy--what should be done?] 18 Aug 2009
• Screening for epidermal growth factor receptor mutations in lung cancer. 17 Aug 2009
• Phase II, multicenter, uncontrolled trial of single-agent sorafenib in patients with relapsed or refractory, advanced non-small-cell lung cancer. Aug 2009
• Can the bowel substitute for the kidney in advanced renal failure? 30 Jul 2009
• Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients. 30 Jul 2009
• [Comparative evaluation of adverse reactions between gefitinib and erlotinib treatments in the same patients] 30 Jul 2009
• Gefitinib: a second look. Non-small cell lung cancer: still very disappointing. 30 Jul 2009
• A randomized clinical trial measuring the influence of kefir on antibiotic-associated diarrhea: the measuring the influence of Kefir (MILK) Study. 30 Jul 2009
• Phase II, randomized, double-blind, placebo-controlled study of recombinant human intestinal trefoil factor oral spray for prevention of oral mucositis in patients with colorectal cancer who are receiving fluorouracil-based chemotherapy. 25 Jul 2009
• High dose of arginine enhanced enteral nutrition in postsurgical head and neck cancer patients. A randomized clinical trial. 29 Jun 2009
• Multiple colon ulcerations, perforation and death during treatment of malignant melanoma with sorafenib. 29 Jun 2009
• Use of probiotics for treatment of chemotherapy-induced diarrhea: is it a myth? 23 Jun 2009
• Phase I trial of pazopanib in patients with advanced cancer. 7 Jun 2009
• Infliximab in the treatment of anti-CTLA4 antibody (ipilimumab) induced immune-related colitis. 30 May 2009
• Miglustat in late-onset Tay-Sachs disease: a 12-month, randomized, controlled clinical study with 24 months of extended treatment. 30 May 2009

See a longer list of these articles.

Technical information about 'Diarrhea'

Definition: An increased liquidity or decreased consistency of FECES, such as running stool. Fecal consistency is related to the ratio of water-holding capacity of insoluble solids to total water, rather than the amount of water present. Diarrhea is not hyperdefecation or increased fecal weight.

Descriptor UI: D003967

Alternative terms: Diarrhea; Diarrheas;

Related Mesh Headings: Antidiarrheals; Rehydration Solutions;

Allowable Qualifiers: blood; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; surgery; therapy; urine; veterinary; ultrasonography; virology;

Tree Number: C23.888.821.214;

Technical Notes: in infants = DIARRHEA, INFANTILE + appropriate check tags